Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Nation

Showing results (241-250 of 247) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 247 results.
Antimicrobial Agents and Chemotherapy|September 20, 2022
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream InfectionsCourtney L Luterbach, Hongqiang Qiu, Patrick O Hanafin, et al.
International Journal of Antimicrobial Agents|June 14, 2023
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activityAkosua A Agyeman, Carla López-Causapé, Kate E Rogers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2023
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patientsPatrick O Hanafin, Andrea Kwa, Alexandre P Zavascki, et al.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
Nature Communications|March 26, 2022
A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogensKade D Roberts, Yan Zhu, Mohammad A K Azad, et al.
Cell Chemical Biology|February 4, 2018
Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative BacteriaTony Velkov, Alejandra Gallardo-Godoy, James D Swarbrick, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 2, 2026
Population pharmacokinetics of polymyxin B: an individual participant data meta-analysisSaikumar Matcha, Gauri G Rao, Patrick O Hanafin, et al.
Pageof 25

Showing results (241-250 of 247) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 247 results.
Antimicrobial Agents and Chemotherapy|September 20, 2022
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream InfectionsCourtney L Luterbach, Hongqiang Qiu, Patrick O Hanafin, et al.
International Journal of Antimicrobial Agents|June 14, 2023
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activityAkosua A Agyeman, Carla López-Causapé, Kate E Rogers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2023
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patientsPatrick O Hanafin, Andrea Kwa, Alexandre P Zavascki, et al.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
Nature Communications|March 26, 2022
A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogensKade D Roberts, Yan Zhu, Mohammad A K Azad, et al.
Cell Chemical Biology|February 4, 2018
Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative BacteriaTony Velkov, Alejandra Gallardo-Godoy, James D Swarbrick, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 2, 2026
Population pharmacokinetics of polymyxin B: an individual participant data meta-analysisSaikumar Matcha, Gauri G Rao, Patrick O Hanafin, et al.
Pageof 25